Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings
- PMID: 22035823
- DOI: 10.1016/j.aorn.2011.09.018
Achieving hemostasis with topical hemostats: making clinically and economically appropriate decisions in the surgical and trauma settings
Abstract
Achieving hemostasis is a crucial focus of clinicians working in surgical and trauma settings. Topical hemostatic agents-including mechanical hemostats, active hemostats, flowable hemostats, and fibrin sealants-are frequently used in efforts to control bleeding, and new options such as hemostatic dressings, initially used in combat situations, are increasingly being used in civilian settings. To achieve successful hemostasis, a number of vital factors must be considered by surgeons and perioperative nurses, such as the size of the wound; bleeding severity; and the efficacy, possible adverse effects, and method of application of potential hemostatic agents. Understanding how and when to use each of the available hemostatic agents can greatly affect clinical outcomes and help to limit the overall cost of treatment.
Copyright © 2011 AORN, Inc. Published by Elsevier Inc. All rights reserved.
Similar articles
-
An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis.Pharmacotherapy. 2013 Sep;33(9):935-55. doi: 10.1002/phar.1291. Epub 2013 May 17. Pharmacotherapy. 2013. PMID: 23686938 Review.
-
Implementing methods to improve perioperative hemostasis in the surgical and trauma settings.AORN J. 2010 Nov;92(5):S1-15. doi: 10.1016/j.aorn.2010.08.006. Epub 2010 Oct 15. AORN J. 2010. PMID: 21040810
-
Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.Surg Laparosc Endosc Percutan Tech. 2011 Jun;21(3):131-41. doi: 10.1097/SLE.0b013e31821db688. Surg Laparosc Endosc Percutan Tech. 2011. PMID: 21654294 Review.
-
Comparison of a new fibrin sealant with standard topical hemostatic agents.Arch Surg. 2004 Nov;139(11):1148-54. doi: 10.1001/archsurg.139.11.1148. Arch Surg. 2004. PMID: 15545559 Clinical Trial.
-
Management of surgical hemostasis: topical agents.Vascular. 2008 Mar-Apr;16 Suppl 1:S22-8. Vascular. 2008. PMID: 18544302 Review.
Cited by
-
Electrospun Silk-ICG Composite Fibers and the Application toward Hemorrhage Control.J Funct Biomater. 2024 Sep 19;15(9):272. doi: 10.3390/jfb15090272. J Funct Biomater. 2024. PMID: 39330247 Free PMC article.
-
A hospital cost analysis of a fibrin sealant patch in soft tissue and hepatic surgical bleeding.Clinicoecon Outcomes Res. 2016 Sep 21;8:507-519. doi: 10.2147/CEOR.S112762. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27703386 Free PMC article.
-
Use of a gelatin-thrombin hemostatic matrix in obstetrics and gynecological surgery.Turk J Obstet Gynecol. 2018 Sep;15(3):193-199. doi: 10.4274/tjod.90217. Epub 2018 Sep 3. Turk J Obstet Gynecol. 2018. PMID: 30202631 Free PMC article. Review.
-
Lessons Learned From the Battlefield and Applicability to Veterinary Medicine-Part 1: Hemorrhage Control.Front Vet Sci. 2021 Jan 14;7:571368. doi: 10.3389/fvets.2020.571368. eCollection 2020. Front Vet Sci. 2021. PMID: 33521075 Free PMC article. Review.
-
New insights in large-pores mesoporous silica microspheres for hemostatic application.J Mater Sci Mater Med. 2025 Feb 5;36(1):18. doi: 10.1007/s10856-025-06864-9. J Mater Sci Mater Med. 2025. PMID: 39907851 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical